Vienna - Delayed Quote EUR
Valneva SE (VLA.VI)
2.8820
+0.0220
+(0.77%)
At close: May 27 at 4:00:23 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-46,934
-67,218
-202,744
-245,343
76,901
Investing Cash Flow
-10,758
76,916
-20,585
-29,054
-93,117
Financing Cash Flow
32,557
30,682
63,081
215,116
154,504
End Cash Position
151,505
168,271
126,080
286,532
346,642
Capital Expenditure
-13,385
-16,444
-14,312
-29,322
-93,171
Issuance of Capital Stock
--
--
0
189,837
166,823
Issuance of Debt
--
--
81,111
39,331
859
Repayment of Debt
-5,551
-6,487
-5,224
-4,841
-4,761
Repurchase of Capital Stock
--
--
-240
--
--
Free Cash Flow
-60,319
-83,662
-217,056
-274,665
-16,270
12/31/2021 - 9/8/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVV1.F Novavax, Inc.
6.64
+4.55%
0QF.F Moderna, Inc.
23.90
+2.47%
5CV.F CureVac N.V.
3.7840
+2.55%
5CV.DE CureVac N.V.
3.8080
+4.50%
IFRX InflaRx N.V.
1.8200
-1.62%
RLF.SW Relief Therapeutics Holding SA
2.6350
-8.19%
PCVX Vaxcyte, Inc.
31.73
-2.49%
LXRX Lexicon Pharmaceuticals, Inc.
0.6900
+4.56%
OCGN Ocugen, Inc.
0.9579
+2.91%
MRUS Merus N.V.
50.80
-7.87%